null
ChEBI ID: 35950
| Member | Definition | Role |
|---|---|---|
| 2,3-dinor-6-ketoprostaglandin f1alpha | A prostanoid that is prostaglandin F1alpha lacking two methylenes in the carboxyalkyl chain and bearing an oxo group at the 6-position. | 2,3-dinor-6-oxoprostaglandin F1alpha |
| 3-dehydroquinic acid | A 4-oxo monocarboxylic acid derived from quinic acid by oxidation of the hydroxy group at position 3 to the corresponding keto group. | 3-dehydroquinic acid |
| aminolevulinic acid | The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp. | 5-aminolevulinic acid; 5-ammoniolevulinate |
| benzoylpropionic acid | A 4-oxo monocarboxylic acid that is butyric acid bearing oxo and phenyl substituents at position 4. | 4-oxo-4-phenylbutyric acid |
| fenbufen | fenbufen |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1,107 (16.79) | 18.7374 |
| 1990's | 899 (13.63) | 18.2507 |
| 2000's | 1,593 (24.16) | 29.6817 |
| 2010's | 2,099 (31.83) | 24.3611 |
| 2020's | 896 (13.59) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 736 (10.62%) | 5.53% |
| Reviews | 610 (8.80%) | 6.00% |
| Case Studies | 641 (9.25%) | 4.05% |
| Observational | 33 (0.48%) | 0.25% |
| Other | 4,913 (70.86%) | 84.16% |